期刊文献+

参附注射液对鼠肝脏缺血再灌注损伤的保护作用研究

Protective Effect of Shenfu Injection on in Mouse Partial Live Ischemia/Reperfusion Injury
下载PDF
导出
摘要 目的:观察参附注射液对Wistar大鼠肝脏部分缺血再灌注损伤的保护作用。方法:以Wistar大鼠复制肝脏部分缺血再灌注损伤模型,动物随机分为参附注射液组、对照组(生理盐水注射)及假手术组。动物缺血90min再灌4h采集标本,检测门静脉血清TNF-α、IL-10及血浆ALT水平,肝叶组织常规固定切片HE染色,光镜下观察。结果:肝脏缺血90min再灌注4h后参附注射液组的鼠血清IL-10水平比对照组增高,而血清TNF-α及ALT水平明显降低。结论:参附注射液可以通过提高IL-10、抑制TNF-α减轻肝脏缺血再灌注损伤。 Objective: to investigate the protective effect of Shenfu Injection in mouse partial live ischemia/reperfusion injury in Wistar mice.Methods: The model of the mouse partial live ischemia/ reperfusion injury was established. All the animals were divided randomLy into 3 groups: Shenfu group, vehicle (0.9% sodium chloride solution) group and sham group. Mice were sacrificed after4h to analyze the acute phase of liver IRI. The level of TNF-α , IL-10 and ALT in portal vein were measured in all groups. Pathological sections of liver (HE staining) were used for histological analysis. Resu/ts: After restoration of blood supply, The IL-10 of portal vein was up-regulated markedly in Shenfu group compared to vehicle group, contrary, the level of TNF-α and ALT of portal vein was down-regulated markedly in Shenfu group compared to vehicle group at each point of time in mice partial liver UR injury model. Conclusion: Shenfu Injection raise IL-10 and inhibition the TNF- α mediated inherent immune response and it may play crucial role in lessen the liver UR injury.
作者 翟东升
出处 《辽宁中医药大学学报》 CAS 2009年第11期220-221,共2页 Journal of Liaoning University of Traditional Chinese Medicine
基金 湖北民族学院青年科研基金资助项目
关键词 肝脏 缺血 再灌注 损伤 liver Ischemia reperfusion injury
  • 相关文献

参考文献2

二级参考文献25

  • 1Goebeler M, Gillitzer R, Kilian K, et al. Multiple signaling pathways regulate NF-kappaB-dependent transcription of the monocyte chemoattractant protein -1 gene in primary endothelial cells[J]. Blood, 2001, 97(1):46-55.
  • 2Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappa B pathway in the treatment of inflammation and cancer[J]. J Clin Invest, 2001, 107(2): 135-142.
  • 3Khaled AR, Butfiloski EJ, Sobel ES, et al. Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-κB expression and lymphocyte function[J]. Clin Immunol Immunopathol, 1998, 86(2): 170-179.
  • 4Tomita T, Takano H, Tomita N, et al. Transcription factor decoy for NF-κB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis[J]. Rheumatology, 2000, 39(7): 749-757.
  • 5Chung KC, Park JH, Kin CH, et al. Novel biphasic effect of pyrrolidine dithiocarbamate on neuronal cell viability is mediated by the differential regulation of intracellular zinc and copper ion levels, NF-kappaB, and MAP kinases[J]. J Neurosci Res, 2000, 59(1): 117-125.
  • 6Yokoseki O, Suzuki Ji J, Kitabayashi H, et al. Cis element decoy against nuclear factor-kappa B attenuates development of experimental autoimmune myocarditis in rats[J]. Circ Res, 2001, 89(10): 899-906.
  • 7Ueno T, Sawa Y, Kitagawa-Sakakida S, et al. Nuclear factor-kappaB decoy attenuates neuronal damage after global brain ischemia: A future strategy for brain protection during circulatory arrest[J]. J Thorac Cardiovasc Surg, 2001, 122(4): 720-727.
  • 8Tomita N, Morishta R, Lan HY, et al. In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescetic glomerulonephritis[J]. J Am Soc Nephrol, 2000, 11(7): 1244-1252.
  • 9Shimada H, Moriwaki Y, Kurosawa H, et al. Inflammatory mediator and organ dysfunction syndrome[J]. Nippon Geka Gakkai Zasshi, 1998, 99(8): 490-496.
  • 10Ma W, Lim W, Gee K, et al. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages[J]. J Biol Chem, 2001, 276(17): 13664-13674.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部